128 related articles for article (PubMed ID: 2736484)
1. Intraarterial cisplatin infusion in the management of transitional cell carcinoma of the bladder.
Jacobs SC; Menashe DS; Mewissen MW; Lipchik EO
Cancer; 1989 Jul; 64(2):388-91. PubMed ID: 2736484
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial chemotherapy with cisplatin in advanced urothelial cancer].
Takahashi Y; Uno H; Nagai T; Tamaki M; Nagatani Y; Shinoda I; Takeuchi T; Fujihiro S; Kuriyama M; Kawada Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2806-9. PubMed ID: 2782890
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Lancet; 1999 Aug; 354(9178):533-40. PubMed ID: 10470696
[TBL] [Abstract][Full Text] [Related]
4. [Intraarterial chemotherapy with bladder preservation in patients with invasive bladder carcinoma].
Shiba M; Takatera H; Fujii T; Tokizane T; Shimizu K; Tushima J
Hinyokika Kiyo; 2004 Jan; 50(1):15-9. PubMed ID: 15032009
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
Kuroiwa T; Naito S; Hasuo K; Kishikawa T; Masuda K; Kumazawa J
Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial administration of methotrexate, adriamycin, and cisplatin as neoadjuvant chemotherapy for bladder cancer.
Kuriyama M; Takahashi Y; Nagatani Y; Shinoda I; Yamamoto N; Nagai T; Ueno K; Takeuchi T; Maeda S; Isogai K
Cancer Chemother Pharmacol; 1992; 30 Suppl():S1-4. PubMed ID: 1394808
[TBL] [Abstract][Full Text] [Related]
7. Complications of hypogastric artery cisplatin infusions.
Menashe DS; Jacobs SC
J Surg Oncol; 1989 Jul; 41(3):160-4. PubMed ID: 2545974
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of neoadjuvant intraarterial chemotherapy (I A-MAC) for advanced bladder cancer].
Takahashi Y; Deguchi T; Kuriyama M; Nakano M; Ueno K; Shinoda I; Takeda A; Itoh S; Doi T; Takeuchi T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2311-4. PubMed ID: 7944467
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
10. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter intraarterial infusion of chemotherapy in advanced bladder cancer.
Wallace S; Chuang VP; Samuels M; Johnson D
Cancer; 1982 Feb; 49(4):640-5. PubMed ID: 6799183
[TBL] [Abstract][Full Text] [Related]
12. Transarterial infusion of cisplatin and doxorubicin in bladder cancer.
Mokarim A; Uetani M; Sakamoto I; Hayashi N; Nomata K; Ohtani H
Acta Oncol; 1997; 36(2):175-81. PubMed ID: 9140435
[TBL] [Abstract][Full Text] [Related]
13. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Keating JP; Zincke H; Hahn RG; Morgan WR
Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
[No Abstract] [Full Text] [Related]
14. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced bladder cancer successfully treated with intraarterial chemotherapy].
Takahashi Y; Shinoda I; Nagatani Y; Takeuchi T; Kuriyama M; Kawada Y; Iwata K
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3801-4. PubMed ID: 2596862
[TBL] [Abstract][Full Text] [Related]
16. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
18. Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer.
Mizoguchi H; Nomura Y; Terada K; Nakagawa M; Ogata J
Int J Urol; 1995 Mar; 2(1):17-23. PubMed ID: 7614405
[TBL] [Abstract][Full Text] [Related]
19. [A case of complete response was achieved with arterial infusion chemotherapy including CDDP, etoposide and pirarubicin].
Uekado Y; Watanabe T; Touge H; Inagaki T
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1075-7. PubMed ID: 8512337
[TBL] [Abstract][Full Text] [Related]
20. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
